Report for Q3 2026
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
(603193)"RUNBEN BIOTECHNOLOGY CO., LTD."Report for Q3 2026
Filed with SSE · Stock code 603193 ·
6ix is reading this filing.
View original source (Shanghai Stock Exchange)Runben Biotechnology Co Ltd. on 6ix
Earlier from Runben Biotechnology
- (603193)"RUNBEN BIOTECHNOLOGY CO., LTD."Announcement on Listing and Trading of Certain Restricted Shares from the Initial Public Offering
- Announcement on Implementation of Dividend Distribution for the First Half of 2026
- Announcement on Attending the 2026 Collective Reception Day for Investors in Guangdong Jurisdiction and Interim Performance Briefing for Listed Companies in the Jurisdiction
- Announcement on Resolutions of the 1st Extraordinary General Meeting in 2026
- Announcement on the Profit Distribution Plan for the First Half of 2026
Follow Runben Biotechnology into a list and get an email when it puts out news.
Follow Runben Biotechnology